Research & Education

Locally Advanced NSCLC: Where Are We, Where Do We Go From Here?

Tuesday, May 9, 2017 at 9:00PM EDT - Recording Available



Everett E. Vokes, MD
John E. Ultmann Professor
Chairman, Department of Medicine
University of Chicago
Medicine and Biological Sciences

Ramaswamy Govindan, MD - Program Chair
Co-Director, Section of Medical Oncology
Professor of Medicine
Anheuser-Busch Endowed Chair in Medical Oncology
Director, Section of Oncology
Washington University School of Medicine

Name of Reviewer(s): 


Laurie Gaspar, MD –Nothing to Disclose

Name of Planner(s): 


Pia Hirsch-Nothing to Disclose      Carlos Ferreira-Nothing to Disclose

Name of Activity: 


Locally Advanced NSCLC: Where Are We, Where Do We Go From Here?

Date of Activity:




COI Resolution: Ensure a balanced discussion of alternative. Do not use trade names. Do not refer to company names or logos. Do not recommend therapies.

“All planning committee members’, reviewers, planners and faculty et al. identified conflicts of interest pertaining to this activity were resolved prior to the activity.”

Chair:Ramaswamy Govindan, MD



Speaker: Everett Vokes, MD

Consultant/Advisory Board for: Consultant/Advisory Role: AbbVie, Amgen, AstraZeneca, BMS, Boehringer-Ingelheim, Celgene, Eli Lilly, Genentech, Leidos, Merck, Regeneron, Serono, Takeda, VentiRx.

Type of Activity:

 Live Course

  Internet Live Course (Webinar)XXXX

 Internet Enduring Material

Are there Commercial Supporters for this activity?


If yes, please list:

About the Program:

This webinar will provide an updated overview of current standard therapies for stage III NSCLC.  It will also review the most recent data and current trials likely to impact standards of care.  

Program Objectives:

  • Increase clinician awareness of novel immunotherapeutic and targeted biologic agents that have demonstrated activity in stage IV NSCLC and may be appropriate candidates for clinical trials in earlier stages of disease
  • Review current management of stage III NSCLC, including combined modality approaches and the potential use of immunotherapy, or targeted biologic agents
  • Identify ongoing clinical trials that are likely to impact patient care in the near future

After viewing this program, attendees will:

  • have a better understanding of current data supporting standard chemoradiotherapy regimens for locally advanced NSCLC;
  • be able to discuss the rationale for clinical trials evaluating the integration of immunotherapies into standard treatment paradigms;
  • have an awareness of the preliminary data emerging from combined modality trials incorporating immunotherapy for stage III NSCLC;
  • be able to address the use of targeted therapies in the setting of stage locally advanced disease.

Following the presentation, there will be ample time for discussion and a question/answer session.  Attendees will be able to submit questions and comments to Dr. Volkes via internet chat.

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.

In order to receive CME credit, attendees must fill out a program evaluation.

Financial/Commercial and Conflicts of Interest Disclosures

IASLC Financial/Commercial Relationships and Conflicts of Interest Policy

IASLC Honoraria Policy

IASLC Commercial Support Agreement (LOA)


Please complete the evaluation link provided to you after the activity. The certificate of credit will be ready for you to print or save for your records.

Attendees can now view IASLC Live webinars via their mobile device. Downloading of the Cisco WebEx Meetings app is required.

  • For Droid users, download the Cisco WebEx Meetings app from the Google Play Store. 
  • For iPad & iPhone users, download the Cisco WebEx Meetings app from the App Store.

Once the app is installed on your device you will need to enter the event number for each session. Registration is required for all IASLC webinars.

Use the Time Zone Converter